BDBM50100195 CHEMBL3325805

SMILES CCCC(=O)c1cnn(c1C)-c1ccc(NC(=O)c2cn(CC(=O)N3CCN4CCN(C)C(=O)C4C3)c3ccc(Cl)cc23)cc1

InChI Key InChIKey=QFIIXHNSRPKHPY-UHFFFAOYSA-N

Data  8 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 50100195   

TargetP2Y purinoceptor 12(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50100195(CHEMBL3325805)
Affinity DataIC50:  7nMAssay Description:Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50100195(CHEMBL3325805)
Affinity DataIC50:  8nMAssay Description:Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50100195(CHEMBL3325805)
Affinity DataIC50:  7nMAssay Description:Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Rattus norvegicus)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50100195(CHEMBL3325805)
Affinity DataIC50:  300nMAssay Description:Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50100195(CHEMBL3325805)
Affinity DataIC50:  300nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50100195(CHEMBL3325805)
Affinity DataIC50:  300nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Rattus norvegicus)
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50100195(CHEMBL3325805)
Affinity DataIC50:  300nMAssay Description:Antagonist activity at P2Y12 receptor in Sprague-Dawley rat platelet rich plasma assessed as inhibition of ADP-induced aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetP2Y purinoceptor 12(Homo sapiens (Human))
Sanofi R & D

Curated by ChEMBL
LigandPNGBDBM50100195(CHEMBL3325805)
Affinity DataIC50:  300nMAssay Description:Antagonist activity at P2Y12 receptor in human platelet rich plasma assessed as inhibition of ADP-induced aggregationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed